Double Replacement Gene Targeting for the Production of a Series of Mouse Strains with Different Prion Protein Gene Alterations

Article metrics

Abstract

We have developed a double replacement gene targeting strategy which enables the production of a series of mouse strains bearing different subtle alterations to endogenous genes. This is a two-step process in which a region of the gene of interest is first replaced with a selectable marker to produce an inactivated allele, which is then re-targeted with a second vector to reconstruct the inactivated allele, concomitantly introducing an engineered mutation. Five independent embryonic stem cell lines have been produced bearing different targeted alterations to the prion protein gene, including one which raises the level of expression. We have constructed mice bearing the codon 101 proline to leucine substitution linked to the human familial prion disease, Gerstmann-Straussler-Scheinker syndrome. We anticipate that this procedure will have applications to the study of human inherited diseases and the development of therapies.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Melton, D.W. 1994. Gene targeting in the mouse. BioEssays 16: 633–638.

  2. 2

    Mansour, S.L., Thomas, K.R. and Capecchi, M.R. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting, mutations to non-selectable genes. Nature 336: 348–352.

  3. 3

    Bradley, A., Evans, M., Kaufman, M.H. and Robertson, E. 1984. Formation of germline chimeras from embryo-derived teratocarcinoma cell lines. Nature 309: 255–256.

  4. 4

    Snouwaert, J.N., Brigman, K.K., Latour, A.M., Malouf, N.N., Boucher, R.C., Smithies, O. and Roller, B.H. 1992. An animal model for cystic fibrosis made by gene targeting. Science 257: 1083–1088.

  5. 5

    Dorin, J.R., Dickinson, P., Alton, E.W.F.W., Smith, S.N., Geddes, D.M., Stevenson, B.J., Kimber, W.L., Fleming, S., Clarke, A.R., Hooper, M.L., Anderson, L., Beddington, R.S.P. and Porteous, D.J. 1992. Cystic fibrosis in the mouse by targeted insemonal mutagenesis. Nature 359: 211–215.

  6. 6

    Tybulewicz, V.L.J., Tremblay, M.L., LaMarca, M.E., Willemsen, R., Stubblefleld, B.K., Winfield, S., Zablocka, B., Sidransky, E., Martin, B.M., Huang, S.P., Mintzer, K.A., Westphal, H., Mulligan, R.C. and Ginns, E.I. 1992. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene. Nature 357: 407–410.

  7. 7

    Rubin, E.M. and Smith, D.J. 1994. Atherosclerosis in mice: getting to the heart of a polygenic disorder. Trends in Genetics 10: 199–203.

  8. 8

    Kerem, B.-S., Rommens, J.M-., Buchanan, J.A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M. and Tsui, L.-C. 1989. Identification of a cystic fibrosis gene: genetic analysis. Science 245: 1073–1080.

  9. 9

    Prusiner, S.B. and Hsaio, K.K. 1994. Human prion diseases. Ann. Neurol. 35: 385–395.

  10. 10

    Prusiner, S.B. 1994. Inherited prion diseases. Proc. Natl. Acad. Sci. USA 91: 4611–4614.

  11. 11

    Palmer, M.S., Dryden, A.J., Hughes, T. and Collinge, J. 1991. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352: 340–341.

  12. 12

    Goldfarb, L.G., Petersen, R.B., Tabaton, M., Brown, P. et al. 1992. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258: 806–807.

  13. 13

    Carlson, G.A., Kingsbury, D.T., Goodman, P.A., Coleman, S., Marshall, S.T., DeArmond, S., Westaway, D. and Prusiner, S. B. 1986. Linkage of prion protein and scrapie incubation time genes. Cell 46: 503–511.

  14. 14

    Westaway, D., Goodman, P.A., Mirenda, C.A., McKinley, M.P., Carlson, G.A. and Prusiner, S.B. 1987. Distinct prion proteins in short and long scrapie incubation period mice. Cell 51: 651–662.

  15. 15

    Hasty, P., Ramirez-Solis, R., Krumlauf, R. and Bradley, A. 1991. Introduction of a subtle mutation into the Hox 2.6 locus in embryonic stem cells. Nature 350: 243–246.

  16. 16

    Stacey, A., Schnieke, A., McWhir, J., Cooper, J., Colman, A. and Melton, D.W. 1994. Use of double-replacement gene targeting to replace the murine α-lactalbumin gene with its human counterpart in embryonic stem cells and mice. Mol. Cell. Biol. 14: 1009–1016.

  17. 17

    Magin, T.M., McWhir, J. and Melton, D.W. 1992. A new mouse embryonic stem cell line with good germ line contribution and gene targeting frequency. Nucl. Acid. Res. 20: 3795–3796.

  18. 18

    Westaway, D., Cooper, C., Turner, S., Da Costa, M., Carlson, G.A. and Prusiner, S.B. 1994. Structure and polymorphism of the mouse prion protein gene. Proc. Natl. Acad. Sci. USA 91: 6418–6422.

  19. 19

    Palmiter, R.D and Brinster, R.L. 1986. Germ-line transformation of mice. Ann. Rev. Genet. 20: 465–499.

  20. 20

    Scott, M., Foster, D., Mirenda, C., Serban, D., Coufal, F., Walchli, M., Torchia, M., Groth, D., Carlson, G., DeArmond, S.J., Westaway, D. and Prusiner, S.B. 1989. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59: 847–857.

  21. 21

    Prusiner, S.B., Scott, M., Foster, D., Pan, K.-M., Groth, D., Mirenda, C., Torchia, M., Yang, S.-L., Serban, D., Carlson, G.A., Hoppe, P.C., Westaway, D. and DeArmond, S.J. 1990. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63: 673–686.

  22. 22

    Scott, M., Groth, D., Foster, D., Torchia, M., Yang, S.-L., DeArmond, S.J. and Prusiner, S.B. 1993. Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell 73: 979–988.

  23. 23

    Hsaio, K.K., Scott, M., Foster, D., Groth, D.F., DeArmond, S.J. and Prusiner, S.B. 1990. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250: 1587–1590.

  24. 24

    Westaway, D., DeArmond, S.J., Cayetano-Canlas, J., Groth, D., Foster, D., Yang, S.-L., Torchia, M., Carlson, G.A. and Prusiner, S.B. 1994. Degeneration of skeletal muscie, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild- type prioh proteins. Cell 76: 117–129.

  25. 25

    Games, D., Adams, D., Alessandrini, R., Barbour, R. et al. 1995. Alzheimer-type neuropathology in transgenic mice overexpressing V717F α-amyloid precursor protein. Nature 373: 523–527.

  26. 26

    Xu, Z., Cork, L.C., Griffin, J.W. and Cleveland, D.W. 1993. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 73: 23–33.

  27. 27

    Cote, F., Collard, J.-F. and Julien, J.-P. 1993. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model for amylotrophic lateral sclerosis. Cell 73: 35–46.

  28. 28

    Deng, C., Thomas, K.T. and Capecchi, M.R. 1993. Location of crossovers during gene targeting with insertion and replacement vectors. Mol. Cell. Biol. 13: 2134–2140.

  29. 29

    Taki, S., Meiering, M. and Rajewsky, K. 1993. Targeted insertion of a variable region gene into the immunoglobulin heavy chain locus. Science 262: 1268–1271.

  30. 30

    Detloff, P.J., Lewis, J., John, S.W., Shehee, W.R., Langenbach, R., Maeda, N. and Smithies, O. 1994. Deletion and replacement of the mouse adult β-globin genes by a “plug and socket” repeated targeting strategy. Mol. Cell. Biol. 14: 6936–6943.

  31. 31

    Valancius, V. and Smithies, O. 1991. Testing an “in-out” targeting procedure for making subtle alterations in mouse embryonic stem cells. Mol. Cell. Biol. 11: 1402–1408.

  32. 32

    Ramirez-Solis, R., Zeng, H., Whiting, J., Krumlauf, R. and Bradley, A. 1993. Hoxb-4 {Hox 2.6) mutant mice show homeotic transformation of a cervical vertebra and defects in the closure of the sternal rudiments. Cell 73: 279–294.

  33. 33

    Wu, H., Liu, X. and Jaenisch, R. 1994. Double replacement: strategy for efficient introduction of subtle mutations into the murine Collα-1 gene by homologous recombination irk embryonic stem cells. Proc. Natl. Acad. Sci. USA 91: 2819–2823.

  34. 34

    Ernst, M., Gearing, D.P. and Dunn, A.R. 1994. Functional and biochemical association of Hck with the LlF/IL-6 receptor signal transducing subunit gpl30 in embryonic stem cells. EMBO J. 13: 1574–1584.

  35. 35

    Reid, L.H., Gregg, R.G., Smithies, O. and Koller, B.H. 1990. Regulatory elements in the introns of the humart HPRT gene are neccessary for its expression in embryonic stem cells. Proc. Natl. Acad. Sci. USA 87: 4299–4303.

  36. 36

    Askew, G.R., Doetschman, T. and Lingrel, J.B. 1993. Site-directed point mutations in embryonic stem cells: a gene-targeting tag-and-exchange strategy. Mol. Cell. Biol. 13: 4115–4124.

  37. 37

    Kunkel, T.A., Roberts, J.D. and Zakour, R.A. 1987. Rapid and efficient site specific mutagenesis without phenotypic selection. Meth. Enzymol. 154: 367–382.

  38. 38

    Magin, T.M., McEwan, C., Milne, M., Pow, A.M., Selfridge, J. and Melton, D.W. 1992. A position- and orientation-dependent element in the first intron is required for expression of the mouse hprt gene in embryonic stem cells. Gene 122: 289–296.

  39. 39

    Selfridge, J., Pow, A.M., McWhir, J., Magin, T.M. and Melton, D.W. 1992. Gene targeting using a mouse HPRT minigene/HPRT-deficient embryonic stem cell system: inactivation of the mouse ERCC-1 gene. Som. Cell. Mol. Genet. 18: 325–336.

  40. 40

    Miller, S.A., Dykes, D.D. and Polesky, H.F. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acid. Res. 16: 1215.

  41. 41

    Thompson, S., Clarke, A.R., Pow, A.M., Hooper, M.L. and Melton, D.W. 1989. Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells. Cell 56: 313–321.

  42. 42

    Melton, D.W., Konecki, D.S., Ledbetter, D.H., Hejtmancik, J.F. and Caskey, C.T. 1981. In vitro translation of hypoxanthine/guanine phosphoribosyltrans-ferase mRNA; characterisation of a mouse neuroblastoma cell line that has elevated levels of hypoxanthine/guanine phosphoribosyltransferase protein. Proc. Natl. Acad. Sci. USA 78: 6977–6980.

  43. 43

    Minty, A.J., Caravatti, M., Robert, B., Cohen, A., Daubas, P., Weydert, A., Gros, F. and Buckingham, M. 1981. Mouse actin messenger RNAs: construction and characterization of a recombinant plasmid molecule containing a complementary DNA transcript of mouse α-actin mRNA. J. Biol. Chem. 256: 1008–1014.

Download references

Author information

Correspondence to David W. Melton.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Moore, R., Redhead, N., Selfridge, J. et al. Double Replacement Gene Targeting for the Production of a Series of Mouse Strains with Different Prion Protein Gene Alterations. Nat Biotechnol 13, 999–1004 (1995) doi:10.1038/nbt0995-999

Download citation

Further reading